semaglutide after breast cancer is Associated with Improved Survival, Lower Metastatic Burden, and a Dose–Survival Relationship Uncoupled from Weight-Loss Magnitude[v1] GLP-1s appear to cut cancer
Pay in 4 interest-free payments of $5.14 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
![semaglutide after breast cancer is Associated with Improved Survival, Lower Metastatic Burden, and a DoseSurvival Relationship Uncoupled from Weight-Loss Magnitude[v1] GLP-1s appear to cut cancer](https://npr.brightspotcdn.com/dims3/default/strip/false/crop/5400x3600+0+0/resize/5400x3600!/?url=http%3A%2F%2Fnpr-brightspot.s3.amazonaws.com%2F32%2F86%2F765aa4704e13aac27deda3103de6%2Fgettyimages-2279484839.jpg)
![semaglutide after breast cancer is Associated with Improved Survival, Lower Metastatic Burden, and a DoseSurvival Relationship Uncoupled from Weight-Loss Magnitude[v1] GLP-1s appear to cut cancer](https://cdn.prod.website-files.com/68072c16317fc2e0431a5348/6911b81d0ef866ee962255ec_8N0ChMXQUuOHIgCQk7SF3aAPi6bdCWDAbZf39hFxYEo.png)
![semaglutide after breast cancer is Associated with Improved Survival, Lower Metastatic Burden, and a DoseSurvival Relationship Uncoupled from Weight-Loss Magnitude[v1] GLP-1s appear to cut cancer](https://www.sciencealert.com/images/2026/06/BreastCancer.jpg)


















